Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Pegfeel 6mg Injection
Manufacturer/Marketed By : DR REDDY'S LABORATORIES LTD
$36.36 $16.36
Sidmex Inovia offers bulk export supply of Pegfeel 6mg Injection (PEGYLATED GRANULOCYTE COLONY STIMULATING FACTOR) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.Documents,...
PEGYLATED GRANULOCYTE COLONY STIMULATING FACTOR
Active Pharmaceutical Ingredient
Pegfeel 6mg Injection
$36.36
$16.36
Sidmex Inovia offers bulk export supply of Pegfeel 6mg Injection (PEGYLATED GRANULOCYTE COLONY STIMULATING FACTOR) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.
Documents, cold-chain shipping and tenders: see our Export FAQ.
Priority markets: United Arab Emirates, Brazil, Turkey, Singapore, Kenya, Somalia, Ghana, Saudi Arabia, Mauritius, Nigeria, Tanzania, Senegal, Democratic Republic of the Congo, Mali. We also export worldwide, including:
Middle East: Oman, Qatar, Kuwait, Bahrain, Iraq, Jordan, Lebanon, Yemen, Iran
Africa: Egypt, Algeria, Morocco, Libya, Burkina Faso, Côte d'Ivoire, Gambia, Rwanda, Ethiopia, Djibouti, South Africa, Zimbabwe
Asia: Sri Lanka, Bangladesh, Nepal, Maldives, Philippines, Vietnam, Laos, Malaysia, Thailand, Taiwan
CIS & Eastern Europe: Russia, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Serbia, Latvia, Tajikistan
Latin America & Caribbean: Mexico, Chile, Peru, Colombia, Bolivia, Venezuela
Europe & Other: Switzerland, United Kingdom, Canada
Related products we supply: Pegfeel 6 mg PFS
Pegfeel 6mg Injection consists of the active Peglylated granulocyte colony-stimulating factor. This is synthesized from the bacteria E.coli. It belongs to a category of proteins called cytokines and is similar to the natural protein produced by the body. It is a leukocyte growth factor indicated to reduce infections in patients receiving anti-cancer drugs with bone marrow suppressive properties. By reducing the risk of infections, Pegfeel 6mg Injection can help cancer patients receive their full dose of chemotherapy on schedule, improving treatment outcomes. This medication is also prescribed to increase the survival of patients exposed to radiotherapy. Patients who receive Pegfeel 6mg Injection may experience less fatigue, fewer days of fever and infection, and less time spent in the hospital. This can lead to an improved quality of life during cancer treatment. This can interfere with bone marrow function testing, such as aspiration and biopsy, and cause false-positive results. Patients should inform their healthcare provider that they receive Pegfeel 6mg Injection before undergoing any bone marrow function testing.
Active Pharmaceutical Ingredient
Uses
• Chemotherapy-induced neutropenia
• Chemotherapy-induced fever
• Chemotherapy-induced infections
Benefits
The therapeutic effect of Pegfeel 6mg Injection is to stimulate the production of neutrophils in the bone marrow. Neutrophils are a type of white blood cell that help to fight infections. Chemotherapy drugs can cause damage to the bone marrow, leading to a decrease in the number of neutrophils, which can increase the risk of infections. So this medication works by stimulating the bone marrow to produce more neutrophils, which can help prevent infections in cancer patients undergoing chemotherapy. This can reduce the risk of infections, hospitalizations, and other complications associated with chemotherapy-induced neutropenia.
Side Effects
Like all medications, Pegfeel 6mg Injection causes some side effects, although not everyone will experience them.
Most Common Side Effects
• Bone pain
• Headache
• Fatigue
• Muscle aches
• Nausea
• Vomiting
• Diarrhea
• Loss of appetite
• Injection site reactions
Common Side Effects
• Allergic reactions
• Acute respiratory distress syndrome (ARDS)
• Splenic rupture
• Kidney damage
• Interstitial lung disease (ILD)
How To Use
Pegfeel 6mg Injection is administered as an injection under the skin. The injection should be given in the abdomen (at least 2 inches away from the belly button), the front of the thighs, or the upper arm. It is usually administered once per chemotherapy cycle. The medication should be administered at least 24 hours after the last dose of chemotherapy to allow for proper bone marrow recovery.
Safety Advice
• Breast Feeding: It is unknown whether Pegfeel 6mg Injection is excreted in human milk. So breastfeeding women should consult their doctor before taking it.
• Alcohol: Alcohol use can negatively affect the immune system, and patients receiving Pegfeel 6mg Injections may already have compromised immune systems due to their medical condition or treatment. Therefore, it is generally recommended that patients limit their alcohol consumption or avoid alcohol entirely while receiving it.
• Liver: If a patient with liver disease experiences symptoms such as yellowing of the skin or eyes, abdominal pain, or dark urine while receiving Pegfeel 6mg Injection, they should notify their healthcare provider immediately.
• Lungs: Pegfeel 6mg Injection may cause a side effect called interstitial lung disease (ILD), a serious lung condition that can cause symptoms such as shortness of breath, coughing, and fatigue. Patients with pre-existing lung disease may be at a higher risk of developing ILD while receiving this medicine.
• Driving: Patients should always monitor their response to the medication and be cautious when driving or operating machinery if they experience any side effects that may impair their ability to do so safely.
• Pregnancy: Pegfeel 6mg Injection may harm the developing fetus, so it is unsafe to use it during pregnancy.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.